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ABSTRACT
When I first started my graduate journey at The University of Rhode Island, I knew
I wanted to pursue my research in an organic chemistry research group. I was drawn to
the DeBoef Group, as their research was profoundly interesting in the sense where the
group conducted research in various fields. Where each group had a name amongst the
graduate students, such as “the nanopore group”, or “the polymer group”, the DeBoef
Group was just what it truly is at heart, “the synthesis group”. I always wanted to be a
synthetic chemist, I enjoyed the work, and taking something from pen and paper and
producing a tangible product in the lab. I always thought the field of synthetic chemistry
was quite beautiful in that sense. But, I guess at heart… I’m a synthetic chemist, which
is why there was never any other option than to join the DeBoef Group.
At the time when I joined, in 2017, the research being conducted was dividied into
two subgroups: C-H activation, including inventing new reaction methodology, and supramolecular chemistry work involving binding studies for mainly biosensing purposes.
However, as the years went by, these subgroups became quite diverse in their applications and synthetic approaches. As an undergraduate, I had done some undergraduate
research work involving C-H activation, so there was a sense of familiarity within the
group. However, I was drawn to the more unknown facet, which was the supramolecular
chemistry, or host-guest interaction, side.
I started my Ph.D. work on a C-H activation project, in which the premise involved
utilizing electron withdrawing nitrogen groups, versus commonly used electron donating nitrogen groups, to catalytically induce an intramolecular transformation to form

nitrogen-containing heterocycles, something of substantial interest to the field of pharmaceuticals.
My first year I did get some promising preliminary data, and presented my work at
the American Chemical Society Regional Meeting in Boston in 2018, at the end of my
first summer. However, after many arduous hours, we concluded that the idea wasn’t as
plausible as we had hoped – something I found to be quite common in the field of synthetic research specifically. I continued to work on the project for a short time after that
and later deciding to switch to the “other side” of the DeBoef Group, the side I was
initially drawn to – supramolecular host-guest chemistry.
I started this research by helping a co-worker in the group, Ashvin I. Fernando,
who later became a great friend and mentor to work with. I owe a lot of my advanced
skills to his expertise in the supramolecular field. I started this research by working on
synthesizing pillar[n]arenes, specifically pillar[5]arenes, (P5As), which are known macrocycles consisting of repeating benzene units linked by methylene bridges. P5A which
are host-like molecules typically possess a hydrophobic inner cavity, perfect for binding
hydrophobic moieties, including hydrophobic small molecules or hydrophobic gases,
such as 129-Xenon, which will be mentioned frequently. My role with P5A was to synthesize it in large quantities and further functionalize their carbon chains, or carbon
linkers, with various terminal end groups, both symmetrically and asymmetrically. This
opportunity gave me a completely new view on synthetic chemistry. I am very grateful
for having worked with Ashvin on his various P5A projects to learn, not only a new way
of synthetically thinking, but to learn different, more complex, purification skills and
syntheses setups.

This research led me to gravitate towards a different group of macrocycles, primarily cyclodextrins, (CDs), which are quite well-known and prevalent in many fields outside of just chemistry. The reason I was drawn to CDs specifically was because they
were known to possess a unique hydrophilic/hydrophobic duality. Meaning, while still
being able to bind a hydrophobic guest, they still, in most cases, maintained water solubility due to the exterior alcohol groups encompassing this molecule. Which for biological purposes, such as drug delivery - what I was interested in exploring and was
something our group had not yet done yet, was ideal. In this dissertation, the reader will
explore some interesting findings regarding cyclodextrin binding in Chapter one and
Chapter two.
Chapter one focuses on the development of [2] and [3] CD-based rotaxanes, with
an interesting twist towards the end, involving what we coined as a quasi[3]rotaxane –
seemingly a [3]rotaxane but not quite as the complex is not fully kinetically locked in
place. In this chapter, my personal favorite, the reader will learn about the synthesis of
the rotaxanes, how important the chosen guest was to the work, the robustness of the
rotaxanes, how we developed higher order ternary complexes using a small hydrophobic
drug-mimic to demonstrate proof of concept – that it is, in fact, possible to generate a
ternary complex for drug delivery, and how we can apply this system to a real life setting.
Chapter two focuses on fundamental findings regarding CD-based pseudorotaxanes, and focuses on their binding abilities by alternating between various guests. In this
chapter, the exploration of the non-covalent driving focuses are discussed. Additionally,
this chapter confirms some of the hypotheses presented in chapter one to demonstrate
what is occurring, and lastly, how this system could potentially be used for drug delivery.

In chapter three, another macrocycle is introduced that was explored in our group
before, cucurbit[n]urils, (CBs), specifically cucurbit[6]uril, (CB6). This macrocycle is
different in structure, yet similar, to the previously mentioned macrocycles, in the sense
that is it composed of glycouril subunits instead of glucose subunits (like CDs), but also
has a hydrophobic cavity ideal for binding hydrophobic molecules, importantly 129Xe
gas – a known hydrophobic gas. This is significant because it can produce a HyperCEST
signal, in which CEST stands for Chemical Exchange Saturation Transfer. Simply put,
this is an eloquent way of signal amplification coupled with Xenon-based MRI, a relatively new form of MRI that is much more advantageous to regularly used proton MRI.
As the reader will explore in Chapter three, we propose a new and innovative way
to combine a CB6-based biosensor with this molecular imaging platform as a way of
detecting early symptoms of lung cancer. The reader will learn more about HyperCEST
129

Xe MRI, and why it is so advantageous over proton MRI. Additionally, this chapter

will primarily focus on the synthesis of the molecular imaging biosensor, the CB6-based
cleavable rotaxane. Lastly, this chapter will conclude with how this should work in a
true environment to ultimately contribute to less late detected lung cancer cases.
Drug delivery and Xenon binding are both common themes that drove the ideas
and syntheses discussed throughout, that the reader will see trends of the research conducted herein. It is important to note that the HyperCEST 129-Xenon MRI studies, in
all cases, were done in collaboration with several individuals, listed as authors in chapter
three, at the Department of Chemistry at Lakehead University and Thunder Bay Regional Research Institute, both in Thunder Bay, Ontario, Canada.

Ultimately, I want to conclude this by stating the primary role of the DeBoef Group,
has been and always will be, the synthesis. We are “the synthesis group” through and
through. Whether it be new reaction development, creating macrocycles, or creating
guest species for binding, we will always focus on the synthesis, and taking our ideas
off the paper, (to be honest, off the the office windows), and applying them experimentally in the lab. Additionally, I’d like to state that all the synthetic work was done at the
University of Rhode Island Department of Chemistry in conjunction with the Teknor
Apex instrumentation laboratory.
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PREFACE
The dissertation written herein is presented in the format according to the graduate
school of the University of Rhode Island guidelines. The manuscript format is presented
herein. The research described is divided into three chapters in the form of three separate
manuscripts, all including an abstract with a TOC (table of contents) figure, followed
by an introduction to familiarize the reader with the work, results of the work, and a
conclusion and discussion section at the end of the chapter. Followed by each chapter
will by a supplemental information section, which contains any experimental methods
and compound characterization relevant to the work in each chapter. The first chapter
is in preparation to be submitted for publication to the Journal of the American Chemical Society, (JACS). The second chapter is in preparation to be submitted to ChemRxiv
website, which is a free access pre-publication platform to publish research outputs
within the chemistry field. Lastly, the third chapter is in preparation for submission. All
three manuscripts contain a detailed title page, including chapter title, author list, and
journal name with timescale of publication.
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ABSTRACT
A versatile, three component, one-pot synthesis of multifaceted [2] and [3]-CDbased rotaxanes have been synthesized and characterized. The key end-capping, or
locking mechanism, to form the rotaxane from the inclusion complex involves a fundamental Diels-Alder [4+2] cycloaddition, which can further be used to synthesize
1:1, 1:2, and 2:1 rotaxanes. These syntheses can be performed on gram-scale, resulting
in high yields of pure rotaxane products due to the significance of the chosen guest.
Moreover, these rotaxanes possess the ability to be further functionalized at the
end-caps using various affinity tags, fluorophores, or chemical probes based on the desired application. This is synthetically demonstrated by the functionalization of the
maleimide end-caps, which we were able to attach a Thioflavin-T, (ThT), affinity tag
– a known dye used to monitor β-amyloid plaques in the brain, often associated with
neurodegenerative diseases, such as Alzheimer’s.
The [2]rotaxanes synthesized and discussed herein are able to reversibly form
originally devised quasi[3]rotaxanes, or higher order ternary complexes of the [2]rotaxane with additional small molecules, i.e. a lipophilic drug moiety.
The synthesis of a quasi[3]rotaxane containing a small molecule drug is reported
herein, thus demonstrating a potential new scaffold for drug delivery. With this relatively simplistic, yet robust, system, we are also able to exchange out the third component and introduce 129Xe for the use of this system as a biosensor coupled with HyperCEST 129Xe MRI, which allows for a possible system of targeted drug delivery.
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1. INTRODUCTION
Mechanically interlocked supramolecular complexes, such as rotaxanes, have
been of notable interest in the last few decades due to their wide variety of
applications. These range from catalysis, biosensing, hydrogel formation,
environmental remediation, and drug delivery, among others.1-4 Rotaxanes are
synthesized in various ways, one of them being by threading a linear axle-like
molecule through a macrocyclic host. The thread is then locked in place by bulky
molecular caps that are attached to the ends of the axle, preventing the linear axle-like
guest from being dethreaded.4,5
Cyclodextrins (CDs) are well known macrocycles consisting of cyclic
oligosaccharides containing six, seven, or eight glycopyranose repeating units. They
are both hydrophobic and hydrophilic in nature; their outer surface allows for an
extensive hydrogen bonding network to take place while their interior remains entirely
hydrophobic.6 CDs are regularly used in the pharmaceutical industry, among others, in
which CDs are used to enhance the physiochemical properties of a small molecule
drug.6-8 This is an appealing feature in terms of rotaxane development.
Our interest in the field of mechanically interlocked complexes stems from our
previous synthesis of CD-based pseudorotaxanes, in which we were able to
demonstrate their ability to form ternary complexes with xenon. We found that these
ternary complexes, in conjunction with HyperCEST experiments, were excellent
candidates as potential 129Xe MRI biosensors.2 Based on our previous findings with
CD-based pseudorotaxanes, we were interested in investigating these unique ternary
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structures further with the goal of developing a multi-faceted CD-based scaffold to be
used not only in biosensing, but additionally, in drug delivery.
We commenced our synthetic design based around CD’s ability to bind hydrophobic entities. We initially wanted to synthesize a library of various CD-based rotaxanes using a library of linear threads, however, we found that in this particular case,
PEG-based guests were preferred in comparison to alkyl-based guests. We explored
binding with both β-CD and γ-CD, due to their internal cavity sizes, as these possess
large cavities for ternary complex formation. One of the most common end-capping
synthetic methods for forming rotaxanes involve the use of the copper-catalyzed [3+2]
Hugsien cycloaddition.1,4 Herein, we present an alternative, efficient, and approach to
end-capping rotaxanes using traditional Diels-Alder chemistry. This capping method
can be used to synthesize rotaxanes having a host:guest ratio of 1:1, 2:1, or 1:2 in high
yields and high purities, with relative ease of synthesis.
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Figure 1. Synthetic design of novel CD-based rotaxanes using
Diels-Alder end capping.
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2. RESULTS
As demonstrated in Figure 1, we first synthesized a PEG-based thread
containing terminal anthracenes, 1, and threaded it through the internal cavity of γ-CD,
2, in order to form the pseudorotaxane complex. Next, the pseudorotaxane complex
was reacted with furan protected maleimide, 3. The resulting Diels-Alder adducts, 4,
mechanically locked the PEG thread into the CD cavity. This two-step, one-pot
reaction was successfully repeated using β-CD as well, producing the [2]rotaxane
products, 4 and 5, in 90% and 91% yields. All yields are shown in Figure 2.
The design of the molecular thread proved to be critical for the formation of the
rotaxanes. Interestingly, as shown in Figure 3, we successfully synthesized a library of
alkyl-based threads, both neutral and cationic, to generate a series of rotaxanes.
However, in terms of rotaxane formation, these were synthetically challenging in
comparison to its PEG alternative, 1 when ultimately forming the rotaxanes. We
hypothesized that the oxygens on 1 may form hydrogen bonding interactions with the
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Figure 2. Scope of rotaxanes synthesized with their reported yields.
hydroxy groups in the cavity of the γ-CD, thus allowing for the preference for PEG
chains over alkyl threads.
Once the pseudorotaxane complex formed in situ, they underwent end-capping
via [4+2] cycloadditions using furan protected maleimide, 3. Six rotaxanes, 4-9, were
synthesized, broken down into three types: 1:1, 1:2, and 2:1 host:guest combinations
using β-CD and γ-CD hosts.
The formation of the inclusion complex, 1, and CD can be observed by the
physical appearance of turbidity in the reaction mixture before the addition of the
masked dienophile, 3. Similar observations have been reported with the formation of
poly-pseudorotaxanes and have been attributed to their aggregation via intermolecular
8

hydrogen bonds.9,12 Complexation was monitored through 1H-NMR, in which the
association constant for the 1 with γ-CD, 2, was found to be 2.51 (±0.15) x 103 M-1.
The rotaxanes, 4-9, were characterized using 1H-NMR, 2-D NMR, and high-resolution
mass spectroscopy (see Supporting Information).

Br

N
N

N

N

N

N

N

N

Br

10

12

H
N

N
H

Cl

N
N

Cl

11

13
Unfavorable
for
rotaxane synthesis

Figure 3. Various synthesized neutral and cationic guests attempted to be used
in rotaxane synthesis. Note: all variations of guests range in alkyl chain lengths of 8
to 12 carbons.
As shown in Figure 4, the guest contains a distinguishable singlet in the aromatic
region arising from the proton in the middle of the anthracene core. This singlet shifts
upfield from the aromatic region of the spectrum after the Diels-Alder reaction. In
addition, two small singlets coupled to each other arise from the newly formed C–C
bond. This was a significant indication that the Diels-Alder reaction took place.
Additionally, the protons corresponding to the ethylenes in the guest were shifted
downfield, indicating that they are located in the host’s cavity (Fig. 4). The peaks of
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both the host and guest protons are not broadened, indicating that that the molecule is
a single interlocked rotaxane, not an exchanging inclusion complex.

Figure 4. A) Annotated proton NMR spectrum of 4. B) ROESY of 4. The crosspeak circled in green corresponds to the ethylene protons of guest 1, that are correlated with the internal protons H3 and H5 of CD.
10

As shown in Figure 4B, the most conclusive evidence demonstrating the
formation of the rotaxane is shown in the 2D ROESY spectra of 4. The control
reaction, in which a guest that contained Diels-Alder adduct end caps was mixed with
γ-CD, did not produce these cross peaks. This clearly demonstrates that the
aforementioned syntheses does form kinetically stable rotaxanes. While the anthracene
moieties are small enough to pass through the center of CD, the Diels-Alder adducts
are too bulky for the guest to dethread. Additionally, interactions between the amines
on the guest and the OH2 (Fig. 4A) of γ-CD were observed, indicating that the CD is
positioned between the two amines of guest, as represented schematically, supporting
that hydrogen bonding plays a significant role in how the host and guest are spatially
interacting and bound together. Additionally, the spectra corresponding to the other
synthesized rotaxanes display similar characteristics.
These types of associations are found in cucurbit[n]urils (CBs) based click
chemistry.11 As shown in Figure 2, in the presence of γ-CD, the double Diels-Alder
reaction produced an overall yield of 90% for the rotaxane 4, whereas the same
reaction in the absence of γ-CD only produced only a 45% yield of the double DielsAlder product, (see Supporting Info).
We hypothesize that the excellent yields for the synthesized rotaxane combinations, shown in Figure 2, are examples of cooperative capture synthesis, in which the
cyclodextrin acts as a cofactor that pre-organizes the reagents for the Diels-Alder reaction, leading to increased reaction efficiency.13 Additionally, the maleimide moieties
may be simultaneously playing a role as well, contributing to this phenomenon. We
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suspect, and as seen in literature, the maleimides hydrogen bonding with the peripheral hydroxyl’s on the outer rim of CDs cavity, thus making the dienophile, 3, much
more reactive for the [4+2] cycloaddition.14 This is schematically demonstrated visually in Figure 5.

Figure 5. Schematic of our hypothesis as to why CD catalyzes the reaction and increases the yield profoundly versus the
controlled reaction.

To demonstrate potential targeting ability and robustness of these rotaxanes, a
small molecule affinity tag was linked to the terminal maleimide moieties of the
rotaxane. As demonstrated in Figure 6, we initiated this plan using a synthesized
Thioflavin-T (ThT) based linker, as ThT is a known fluorescent dye that binds to βamyloid plaques in the brain – a common association and indicator of
neurodegenerative disorders.15 Inspired by our previous work on CD-based
pseudorotaxanes as biosensors for HyperCEST 129Xe MRI, we postulated that by
12

attaching a ThT-based linker, we could use these rotaxanes for biosensing and
potential early detection of certain neurological disorders, such as Alzheimer’s. The
synthesis of the dienophile-affinity tag conjugate, 10, is a straight-forward acylation,
allowing for a wide variety of affinity tags or various probes to be attached to the
rotaxane depending on their potential application. In addition, the reaction was
performed on a gram scale and the reaction yields remain consistent, proving that the
reaction can be scaled up with ease.

Figure 6. Synthesis of the ThT-based [2]rotaxane, accomplished by another
[4+2] cycloaddition, yielding the retro Diels-Alder product, 15.
Next, we wanted to investigate another facet of these rotaxanes, specifically the
potential development of ternary complexes that are capable of being used as drug
delivery agents. We postulated that a small hydrophobic drug, ideally a lipophilic
molecule, would be ideal for binding in the interior cavity of our 1:1 CD rotaxane, 4.
We conducted a preliminary experiment involving at 16-carbon alkyl imidazolium
13

guest, to see if this was a plausible hypothesis. As shown in Figure 7, when
conducting an 1H NMR titration, we noticed upfield shifts of the imidazolium region
of the guest, which further supported our idea to bind a small hydrophobic drug in the
cavity of 4. The NMR titrations for 16-C ethyl imidazolium chain and 4 showed an
association constant of 4.98 ± 0.01 x 103 M-1. The cavity space inside the γ-CD
rotaxane is not enough to achieve 1:2 binding.

Figure 7. Proton NMR titration with 4 and a 16-C imidazolium guest. Zoomed in
at the regions of the imidazolium peaks, displaying the shielding effect in the presence of 4. This is indicative that binding is preferential at the cationic site.

Content with our preliminary studies, the class of alkylphospholipids (APLs)
drugs peaked our interest. Namely due to their interesting structural features that
mimicked our previous imidazolium experiment. APLs are a relatively new class of
14

anticancer agents that do not directly interact with DNA, but in turn, interact with the
cell membrane – interfering with lipid metabolism and certain signaling pathways.15 In
order to further demonstrate this idea, of generating a unique ternary complex, we
commenced our investigation using a structurally similar detergent,
dodecylphosphocholine, shown in Figure 9.
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When titrating dodecylphosphocholine into a solution of 4, in DMSO-d6, the polar
groups were more likely to bind into the cavity of γ-CD in comparison to the aliphatic
hydrophobic tail. Interestingly, and consistent with our previous results, CD showed
preferential binding near the hydrogens situated between the charged species. However, when introduced to an aqueous environment, we postulate that hydrophobic interactions will predominate, and subsequently drive the aliphatic portion of the guest
into the cavity of CD. It is also possible that the detergent is bending in the cavity of
CD. The detergent, or drug mimic, showed an association constant of 72.0 ± 0.04 M-1.
Further 2D and computational modeling experiments will verify the relative spatial arrangement of the formed ternary complex, and ultimately demonstrate the viability of
these drug-based ternary complexes and further examine how solvation plays a role in
affecting the binding interactions of the ternary complex.

17

Figure 9. Formation of the ternary complex using 16. Hypothesized arrangement,
17, due to its charged moieties showing interactions via proton NMR.
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3.

CONCLUSION

We have discovered a new, yet fundamental, method for synthesizing rotaxanes
with relative ease of synthesis and high yields. These rotaxanes can also be easily
functionalized to attach fluorophores or affinity tags. Furthermore, we have shown that
these rotaxanes can be potentially used in drug delivery systems to carry small molecule payloads that consist of charged species. Based on our prior studies and the data
presented herein, rotaxane-based ternary complexes appear to be excellent scaffolds
for applications ranging from imaging and drug delivery.
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SUPPLEMENTAL INFORMATION
CHAPTER ONE:
INTRODUCING A QUASI[3]ROTAXANE: THE SYNTHETIC EVOLUTION AND
SUBSEQUENT STUDIES AS A POTENTIAL SUITOR FOR BIOSENSING
AND DRUG DELIVERY

General Considerations:
A. Reagents
All chemicals were purchased from Sigma-Aldrich, Fisher Scientific, and TCI
chemicals, and used as received unless stated otherwise. Deuterated solvents using for
NMR analysis were purchased from Cambridge Isotope Laboratories and stored
appropriately. All reagents were stored under an inert atmosphere before use. Unless
otherwise noted, all reactions were performed under N2.
B. Instrumentation
NMR spectra were obtained using a Bruker Advance 300 MHz and 400 MHz
spectrometers. Low resolution mass spectrometry was performed using a Shimadzu
LRMS-2020. High resolution mass spectrometry was performed using a Thermo
Scientific LTQ Orbitrap XL™ mass spectrometer.
C. Determination of association constants for host cyclodextrins and guests
The NMR titration experiments were conducted per the following procedures. A
series of NMR samples were prepared in 5mm NMR tubes. 10 mM stock solutions of
β-CD, γ-CD, and guests were prepared using DMSO-d6 as the solvent. Using the
above stock solutions, 0.25 mL of the host and 0.25 mL of the guest were mixed inside
23

a GC vial. The threading of the guest into the host was achieved by heating the
solution inside the vial to 60 oC for 5 minutes. This solution was then cooled to room
temperature and transferred to an NMR tube. Physical observation of inclusion
complex was seen by the turbidity of the cooled solution. 1H NMR spectra were then
acquired at 298 K. 1H NMR was performed to see the movement of the protons in the
guest, the movement of the guests after the inclusion complexes were formed, and to
monitor the ternary complex once the interlocked kinetically stable rotaxane was
formed.
The data was evaluated using the “OpenDataFit” website, or
supermolecular.org, which is an online free fitting program.1
The following equation was used to calculate the association constants:
∆ =

∆
2

+{

+

+

1

−(

+

1
+ ) −4

) }

where ∆δ = change in chemical shift after the addition of the guest, [H0] = initial
host concentration, [G0] = initial concentration, and K = association constant. ∆δ was
plotted as a function of the guest concentration.1

1

Thordarson, P. Chem. Soc. Rev. 2011, 40, 1305–1323.
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D. Syntheses and characterization
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Supporting Figure S. 1. Synthesis of precursor of guest (1), imine thread, (1a).
To a stirred solution of 2,2′-(Ethylenedioxy)bis(ethylamine) (730.0 µl, 5.00 mmol) in
3:1 MeOH/CH2Cl2 (10 mL), was added a solution of 9-anthraldehyde (2.16 g, 10.5
mmol) in 3:1 MeOH/CH2Cl2 (10 mL) under inert atmosphere. The mixture was stirred
at room-temperature overnight until the imine formation was complete (monitored by
TLC). The solvent was evaporated under vacuum to give the crude imine product as a
yellow solid, which was used for reduction without further purification. Reaction yield
was 643.7mg (96%). 1H-NMR was performed using DMSO-d6. HRMS ESI (m/z):
[M+H] calculated for C36H33N2O2 525.2542, observed 525.2485. 1H NMR (300 MHz,
DMSO-d6) δ 9.31 (d, J = 1.4 Hz, 2H), 8.62 (s, 2H), 8.55 – 8.45 (m, 4H), 8.14 – 8.04
(m, 4H), 7.57 – 7.47 (m, 8H), 3.97 (t, J = 5.8 Hz, 4H), 3.87 (t, J = 5.4 Hz, 4H), 3.35 (s,
2H), 3.18 (s, 3H).
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Supporting Figure S. 2. Proton NMR of imine thread, (1a).
ESI+_NoRedPEGBa_28Apr2017 #9 RT: 0.13 AV: 1 NL: 9.11E7
T: FTMS + p ESI Full ms [50.00-1000.00]
337.1880
100
90

Relative Abundance

80
70
60
207.0785

50
40
30

338.1913
20
10
0

65.0893
100

179.0839 208.0818
149.1270
294.1464
200

300

525.2485
339.1975
400

475.3209

526.2523
643.3665 674.3746

500

600

700

781.3920
800

861.4329 894.4262
900

m/z

Supporting Figure S. 3. Mass spectrum of imine thread, (1a).
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Supporting Figure S. 4. Synthesis of 1.
NaBH4 (3 equiv.) was added in small portions to the solution of crude imine (1 equiv.)
in 1:1 CH3OH: CH2Cl2 (20 mL) at 0°C. The mixture was stirred at room temperature
overnight, then concentrated under vacuum. The residue was dissolved in CH2Cl2 (50
mL) and washed three times with 50mL of aqueous Na2CO3 (pH=10). The organic
layer was separated, dried over anhydrous Na2SO4, filtered, and concentrated under
vacuum to provide the secondary amines. Reaction yield was 472.2mg, (90%). 1HNMR and 13C-NMR were performed using DMSO-d6. HRMS ESI (m/z): [M+H] calculated for C36H36N2O2 529.2855, observed 529.2794. 1H NMR (300 MHz, DMSOd6) δ 8.50 (s, 2H), 8.40 – 8.31 (m, 4H), 8.05 (dd, J = 7.7, 2.0 Hz, 4H), 7.55 – 7.44 (m,
8H), 4.58 (s, 4H), 3.49 (t, J = 5.6 Hz, 8H), 2.82 (t, J = 5.6 Hz, 4H), 2.03 (br, 2H). 13C
NMR (101 MHz, DMSO-d6) δ 135.0, 132.7, 131.5, 130.3, 129.2, 127.0, 126.3, 125.5,
125.1, 70.5, 70.1, 49.3, 45.2.
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Supporting Figure S. 5. Proton NMR of 1.

28

Supporting Figure S. 6. 13C NMR of 1.
ESI+_RedPEGBa_28Apr2017 #7 RT: 0.10 AV: 1 NL: 5.07E7
T: FTMS + p ESI Full ms [50.00-1000.00]
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Supporting Figure S. 7. Mass spectrum of 1.
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Supporting Figure S. 8. Synthesis of 3.
Maleimide (1.33g, 13.73 mmol) and furan (1.50 ml, 20.66 mmol) were dissolved in 10
mL diethyl ether in a sealed tube and heated to 90-100 °C for 12 hours. The 3, 6-Endoxo-Δ4-tetrahydrophthalhide (furan-protected maleimide) precipitated as a white
solid after cooling the mixture to room temperature. The product was then filtered,
washed with 3x10mL cold diethyl ether to remove the unreacted maleimide. Yield:
(6.04g, 89%). The NMR spectra indicate that the product is exclusively the exo isomer. 1H-NMR and 13C-NMR were performed using DMSO-d6. LRMS ESI (m/z):
[M+H] calculated for C8H7NO3 165.04, observed 165.04. 1H NMR (300 MHz,
DMSO-d6) δ 11.15 (br, 1H), 6.52 (d, J = 0.9 Hz, 2H), 5.11 (t, J = 0.9 Hz, 2H), 2.85 (s,
2H). 13C NMR (101 MHz, DMSO-d6) δ 178.3, 136.9, 80.8, 48.9.
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Supporting Figure S. 9. Proton NMR of 3.
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Supporting Figure S. 10. 13C NMR of 3.

32

Supporting Figure S. 11. Mass spectrum of 3.
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Control reaction: Diels-alder reaction with 1 and 3

Supporting Figure S. 12. Synthesis of capped guest (4a).
2.2 equivalents of furan-protected maleimide, (3), and 1 equiv. of guest (1) was mixed
in 20 mL of toluene. This reaction mixture was refluxed at 110oC for overnight.
Physical observation of the formation of Diels-alder adduct was observed by the
change of colors from yellow solution to white with precipitate. Next, the reaction
mixture was subjected for rotary evaporation until dryness and dried overnight under
high vacuum. Reaction yield: (237.9mg, 45%). 1H-NMR and 13C-NMR were
performed using DMSO-d6. HRMS ESI (m/z): [M+H] calculated for C44H46N4O6
723.3081, observed 723.3083. 1H NMR (400 MHz, DMSO-d6) δ 10.68 (br, 2H), 7.50
(dd, J = 7.3, 1.5 Hz, 2H), 7.42 (dd, J = 6.9, 1.7 Hz, 2H), 7.25 (ddd, J = 7.0, 4.0, 1.9
Hz, 5H), 7.13 (dddt, J = 12.6, 8.7, 5.1, 1.5 Hz, 9H), 4.65 (d, J = 3.3 Hz, 2H), 3.95 (d, J
= 12.3 Hz, 2H), 3.76 (d, J = 12.3 Hz, 2H), 3.66 (d, J = 6.3 Hz, 7H), 3.28 (dd, J = 8.7,
3.1 Hz, 2H), 3.24 – 3.20 (m, 2H), 3.09 – 2.95 (m, 4H), 2.30 (s, 2H), 1.95 (br, 2H). 13C
NMR (101 MHz, DMSO-d6) δ 178.4, 177.9, 143.5, 141.2, 140.4, 129.4, 128.7, 126.8,
126.6, 126.3, 125.2, 124.3, 124.1, 122.8, 70.3, 50.0, 49.1, 48.5, 47.2, 45.0.
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Supporting Figure S. 13. Proton NMR of 4a.
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Supporting Figure S. 14. 13C NMR of 4a.

Supporting Figure S. 15. Mass spectrum of 4a.
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Representative Synthesis of γ-CD rotaxanes, (4, 6, and 8).
Synthesis of γ-CD rotaxanes (4). γ-CD (1 equiv.) and 1 (1 equiv.) was mixed in 20 ml
of toluene. This reaction mixture was ultrasonicated for 15 minutes. Then it was
heated at 80oC for another 15 minutes. To this solution 3 (2.4 equiv.) was added and
the complete reaction mixture was refluxed at 110oC for overnight. Physical observation of the formation of Diels-alder adduct was observed by the change of colors from
yellow solution to white with precipitate to yield 4. Next, the reaction mixture was
subjected for rotary evaporation until dryness and dried overnight under high vacuum.
By altering the molar equivalents between γ-CD and 1, it was possible to obtain 6 and
8. Reaction yields: 90%, 89% and 83% in the order of 1:1, 1:2 and 2:1 host:guest complexes. 1H-NMR, 13C-NMR and ROESY NMR was performed using DMSO-d6.
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Supporting Figure S. 16. Proton spectrum for 4. Zoomed image of Figure 4A.
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Supporting Figure S. 17. 13C NMR of 4.
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Supporting Figure S. 18. ROESY spectrum, mixing time = 500 ms, of 4.
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Supporting Figure S. 19. Mass spectrum of 4.

Supporting Figure S. 20. Mass spectrum of 4. Zoomed at 1006 - 1016 m/z.
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Supporting Figure S. 21. Mass spectrum of 4. Zoomed in at 2017 - 2028 m/z.
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Supporting Figure S. 22. Mass spectrum of 6.
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Supporting Figure S. 23. Mass spectrum of 6. Zoomed in at 2680 - 2780 m/z.

Supporting Figure S. 24. Mass spectrum of 8. Zoomed in at 2620 - 2880 m/z.
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Supporting Figure S. 25. Mass spectrum of 8. Zoomed in at 1655 - 1688 m/z.
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Supporting Figure S. 26. Stacked 1H NMR spectra to confirm 4 successfully
formed. The most indictive shift was the signal at 4.65ppm without CD, but the downfield shift at 4.70ppm when CD was present.
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Supporting Figure S. 27. Stacked 1H NMR spectra to confirm 4 successfully
formed, zoomed in on aromatics. The most indictive shifts were the signals at 7.20,
without CD, then a downfield shift to 7.25 with CD for half the aromatics present. The
second most indicative shifts were the signals at 7.45, without CD, then a downshield
shift to 7.50 when CD was present.
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Representative Synthesis of β-CD rotaxanes, (5, 7, and 9).
Synthesis of β-CD rotaxane (5). β-CD (1 equiv.) and 1 (1 equiv.) was mixed in 20 ml
of toluene. This reaction mixture was ultrasonicated for 15 minutes. Then it was
heated at 80 oC for another 15 minutes. To this solution 3 (2.4 equiv.) was added and
the complete reaction mixture was refluxed at 110oC for overnight. Physical observation of the formation of Diels-alder adduct was observed by the change of colors from
yellow solution to white with precipitate to yield 5. Next, the reaction mixture was
subjected for rotary evaporation until dryness and dried overnight under high vacuum.
By altering the molar equivalents between γ-CD and 1, it was possible to obtain 7 and
9. Reaction yields: 91%, 94%, and 92% in the order of 1:1, 1:2 and 2:1 host:guest
complexes. 1H-NMR, 13C-NMR and ROESY NMR was performed using DMSO-d6.
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Supporting Figure S. 28. Synthesis of ThT-based linker, 5a.
p-Amino Benzoic Acid (2.74 g, 20.0 mmol) and 2-Aminothiophenol (2.14 ml, 20.0
mmol) were dissolved in (21.03 g, 250.00 mmol) polyphosphoric acid. The mixture
was Heated at 200oC and stirred for 4.5 hours. After cooling, 10% Na2CO3 was slowly
poured into solution. This resulted in a greenish mixture. This solution was stirred until gas evolution was completed. Next, the solution was filtered using vacuum filtration. The solid was washed with water (3x50mL) and recrystallized with MeOH and
H2O to give the final product. The yield was 1.7g, (70%). 1H-NMR was performed using DMSO-d6. The literature-based procedure was followed1. LRMS ESI (m/z):
[M+H] calculated for C13H10N2S 227.06, observed 227.05. 1H NMR (400 MHz,
DMSO-d6) δ 8.02 (d, J = 8.0, 1.1 Hz, 1H), 7.90 (d, J = 8.0 Hz, 1H), 7.76 (t, J = 8.7 Hz,
2H), 7.45 (d, J = 7.7 Hz, 1H), 7.34 (d, J = 7.7 Hz, 1H), 6.67 (d, J = 8.6 Hz, 2H), 5.88
(br, 2H).
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Supporting Figure S. 29. 1H NMR of ThT precursor, 5a.
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Supporting Figure S. 30. Mass spectrum of 5a.
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Supporting Figure S. 31. Synthesis of ThT-based linker, 5b.
ThT-NH2 (452.6 mg, 2.00 mmol) was dissolved in 20 ml of anhydrous CH2Cl2. To
this mixture 6-Bromohexonoyl chloride (305.0 µl, 2.00 mmol) was added drop wisely.
The reaction was performed inside a glove box under Nitrogen atmosphere. The reaction mixture was stirred overnight at room temperature. The reaction was monitored
by TLC. After overnight stirring, the mixture was poured into several centrifuge tubes
and centrifuged at 6000 rpm for 15 minutes. Once centrifugation was completed, the
supernatant was discarded. CH2Cl2 was added into the remaining precipitate and centrifuged again. Once again, the supernatant was discarded, and this was done for two
more times with a total of three washes with CH2Cl2. Finally, the remaining precipitate
was dissolved in deuterated CDCl3 and centrifuged, and the precipitate was collected
with the removal of CDCl3. (CDCl3 was used to remove the CH2Cl2 peak from the
spectra.) This was subjected to overnight vacuum. The product was further purified
using automated flash chromatography. The reaction yielded 267mg, (59%). 1H-NMR
and 13C-NMR were performed using DMSO-d6. LRMS ESI (m/z): [M+H] calculated
for C19H19BrN2OS 403.05, observed 403.05. 1H NMR (400 MHz, DMSO-d6) δ 10.25
(s, 1H), 8.12 (dd, J = 8.0, 1.2 Hz, 1H), 8.03 (td, J = 8.7, 7.8, 2.5 Hz, 3H), 7.80 (dd, J =
8.8, 2.6 Hz, 2H), 7.53 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.43 (ddd, J = 8.3, 7.2, 1.2 Hz,
1H), 3.64 (q, J = 6.6 Hz, 1H), 3.55 (t, J = 6.7 Hz, 1H), 2.38 (t, J = 7.4 Hz, 2H), 1.80
(dm, J = 34.0, 7.5, 7.0, 6.8 Hz, 2H), 1.68 – 1.58 (m, J = 7.5 Hz, 2H), 1.44 (t, J = 8.2,
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7.1 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ 172.0, 167.5, 154.1, 142.6, 134.7,
128.5, 127.8, 127.0, 125.7, 123.0, 122.7, 119.6, 45.8, 36.8, 35.5, 32.5, 27.7, 26.4, 24.7.

Supporting Figure S. 32. 1H NMR of 5b.
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Supporting Figure S. 33. 13C NMR of 5b.
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Supporting Figure S. 34. Mass spectrum of 5b.
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Supporting Figure S. 35. Synthesis of 5.
Furan protected maleimide (330.3 mg, 2.00 mmol) and ThT-6-Br (403.3 mg, 1.00
mmol) was dissolved in 10 mL of dry DMF. Next K2CO3 (290.2 mg, 2.10 mmol) was
added and into the mixture. This mixture was heated to 50 ºC for overnight. The literature method only suggested heating for three hours, but this tends to give a mixture of
starting materials and product, but letting it react for overnight helps to get the product
exclusively. The mixture was then dissolved in 50 mL diethyl ether and washed with
5% HCl, followed by water to remove excess DMF. The organic layer was then dried
with magnesium sulfate and subjected to rotatory evaporator until dryness. The product was further purified using automated flash chromatography. The method is given
below. Yield: 208.6mg, (50%). LRMS ESI (m/z): [M+H] calculated for C27H25N3O4S
488.16, observed 488.15. 1H NMR (300 MHz, DMSO-d6) δ 10.20 (s, 1H), 8.15 – 8.09
(m, 1H), 8.06 – 7.99 (m, 3H), 7.79 (td, J = 8.8, 8.8, 5.4 Hz, 2H), 7.53 (ddd, J = 8.3,
7.2, 1.4 Hz, 1H), 7.43 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 6.54 (s, 2H), 5.12 (s, 2H), 3.36
(t, J = 7.1 Hz, 2H), 2.91 (s, 2H), 2.33 (t, J = 7.4 Hz, 2H), 1.60 (p, J = 7.5 Hz, 2H), 1.48
(p, J = 7.2 Hz, 2H), 1.25 (p, J = 9.7, 8.9 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ
178.3, 176.9, 172.1, 172.1, 167.5, 162.8, 154.1, 142.6, 136.9, 134.7, 128.4, 127.7,
127.0, 125.7, 123.0, 122.6, 119.6, 48.9, 47.5, 45.7, 38.2, 36.7, 36.2, 34.7, 32.3, 31.2,
27.4, 26.4, 26.1, 24.9, 24.7.
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Supporting Figure S. 36. 1H NMR of 5.
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Supporting Figure S. 37. 13C NMR of 5.
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Supporting Figure S. 38. Mass spectrum of 5.
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Supporting Figure S. 39. 1H NMR of dodecylphosphocholine. Commercially
available.
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Supporting Figure S. 40. 1H NMR titration in DMSO-d6 with dodecylphosphocholine into 4.
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Supporting Figure S. 41. Zoomed image of S. 42. Showing alkyl region.
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Supporting Figure S. 42. Zoomed image of S. 42 demonstrating no significant
shifting in alkyl peaks from drug.
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Supporting Figure S. 43. Zoomed image of S. 42. Demonstrating the significant
interactions at the zwitterionic region of the drug.
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Supporting Figure S. 44. Zoomed image of S. 42, showing the shifting of the ammonium signal from the drug with 4.
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ABSTRACT
Pseudorotaxanes belong to a class of supramolecular architectures that have
gained popularity due to their general ease of synthesis, ease of modification, low toxicity profiles, and most notably, their ability to “thread” and “dethread” a guest molecule due to changes in equilibrium. This work focuses on feasible synthesis of alkylbased linear guests with charged and uncharged end groups that thread into the hydrophobic cavities of β-cyclodextrin and γ-cyclodextrin. A broad scope of CD-based
pseudorotaxanes have successfully been synthesized and characterized via 1H NMR
titrations in varying concentrations of guest to host. Quantitative analysis to achieve
association constants were determined and analyzed in order to determine the best
suited binary complex, or [2]pseudorotaxane, for ternary complexation. The goal of
this work was to create ternary complexes with alkylphospholipid-based drugs, or
APLs, to determine binding arrangements and affinities to be used for drug binding
analysis and ultimately drug delivery.
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1. INTRODUCTION
Within the past three decades, chemists have tremendously evolved the field of
supramolecular chemistry. In particular, investigating and exploiting the non-covalent
interactions that ultimately drive the creation of such complex molecular architectures.1-4 More recently, Stoddart and co-workers have gained notoriety for winning the
Nobel Prize in 2016 for their work in supramolecular chemistry.5 Since then, this field
has evolved to be quite robust with complex systems involving the synthesis of various unique inclusion complexes, specifically pseudorotaxanes, which will be focused
on herein, shown in Figure 10, but additionally rotaxanes, catenanes, pseudo[n]polyrotaxanes, and polyrotaxanes, to name a few others.6-9

Figure 10. Schematic representation of the pseudorotaxane formation with a
functionalized linear guest and CD host.
Our group has done some previous work involving cyclodextrin-based pseudorotaxanes for the purpose of HyperCEST 129Xe MRI, in which we demonstrated that alkyl imidazolium linear guests, shown in Figure 11, were best suited for forming the inclusion complexes with cyclodextrins, (CDs). We discovered that by binding an additional third component into the CD-based pseudorotaxane, the third component being
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Figure 11. Hosts and guest, 1 and 2, used in previous work involving CD-based
pseudorotaxanes for biosensing purposes. Figure adapted from citation 10.
129

Xe gas, we formed ternary complexes with a the hydrophobic gas. This was ulti-

mately very useful in terms of biosensing, as it produced a significant HyperCEST signal, required for 129Xe MRI.10
This led us to the hypothesis that ternary complexes consisting of an alkyl cationic guest, a CD host, and a drug moiety may be a sufficient paradigm for a drug delivery application. CDs are advantageous in terms of enhancing solubility of hydrophobic small molecule drugs, among other physiochemical properties of hydrophobic
or lipophilic entities.11,12 Additionally, CDs are widely used in a variety of fields ranging from food applications, catalysis, and importantly complexing applications in the
pharmaceutical field. In some cases, the CD can not only enhance solubility of a
poorly soluble drug, but can increase drug bioavailability, activity, and stability.11, 12
With this type of macrocyclic profile, demonstrated in Figure 12, and combined with
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our previous research, we felt secure to conduct further investigations to see if this was
a plausible idea.

Figure 12. Schematic of CD's structure, showing the advantageous hydrophobic
interior and hydrophilic exterior. Figure adapted from: citation 12.
The goal was to generate a library of higher order ternary complexes with a
lipophilic drug-like molecule. Upon determining a well-suited drug candidate, we decided to use something inherently hydrophobic due to the nature of CD’s inner cavity
and known binding profile, however, have seen these interesting trends where cationic
species seem to predominate in complexation.
Alkylphospholipids, for use, are a relatively new class of anticancer drugs,
which exhibit antiproliferative properties.13 These first peaked our interest due to some
preliminary work we conducted in the lab using an 16 carbon imidazolium guest, described in Chapter 1. This guest gave promising results in terms of binding in CD, and
mimicked the structure of APLs. For cost purposes, we found a relatively inexpensive
APL-mimic, dodecylphosphocholine, which maintained the structural integrity of the
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APL drug class, was used in these studies. The structural similarities can be observed
in Figure 13.
The mechanism of action for these drugs was interesting as well, as they do not
directly interact with DNA, but function by disrupting the phospholipid bilayer, therefore interfering with lipid homeostasis. They are also known to exhibit anti-parasitic
effects.13, 14 Therefore, we thought this would be a viable candidate since we could
prove ternary complexation with something molecularly similar to an APL.
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Dodecylphosphocholine

Figure 13. Structural comparison of a known APL, Miltefosine, with our
chosen drug mimic, dodecylphosphocholine, which was used in these studies.
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2. RESULTS
It is important to note, that In these studies we excluded α-CD, as the cavity size
is too small for ternary formation with the chosen drug-like molecule. However, we
did include both β-CD and γ-CD, with their respective internal cavity sizes being ~6.5
Å and ~8.3 Å, for [2]pseudorotaxane formation and subsequently ternary complex
formation. The synthesized scope of guests investigated are shown in Figure 14.
We commenced our pseudorotaxane synthesis by synthesizing all guest species
first, then conducting titrations on β-CD, followed by γ-CD. We hypothesized that the
entirely hydrophobic groups would predominate and show much stronger binding
based off the fundamental knowledge of CD binding. However, interestingly, when in
water, we see more binding around the cationic moieties of the guests versus the aliphatic chains. The PEG-based groups were not ideal for binding in terms of pseudorotaxanes, which was very surprising. When switching the solvent to DMSO-d6, all
groups showed even more promising results in terms of binding – but even then, the
cationic groups, specifically alkyl-based, predominated in terms of largest change in
chemical shift. When considering the application of drug delivery, we changed our
solvent to D2O to mimic biological conditions. All 1H NMR titrations are shown using
D2O in the Supplemental Information.
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Figure 14. Scope of linear guests synthesized for [2]pseudorotaxane formation, in order to determine the best candidate for ternary complexation.

73

Experimentally, all binding patterns were first investigated in terms of their
[2]pseudorotaxane formation, or strictly binary complexation. We first wanted to establish a viable [2]pseudorotaxane that would be well suited for ternary complexation.
Our baseline standards for this included an alkyl cationic guest with both CD’s that
exhibited moderate to strong binding. By conducting 1H proton NMR experiments,
and observing the changes in chemical shift, we were able to qualitatively and quantitatively determine which [2]pseudorotaxane complex was the best suited candidate.
The best way to conduct the 1H NMR titrations was to hold the guest concentration constant, and increase the concentration of host, as described thoroughly in the
supplemental information. The best peaks to monitor were the imidazolium peaks and
the methylene peaks adjacent to the cation, shown in Figure 15.

Figure 15. Abbreviated portion of the alkyl-based cationic guests, highlighting
the best suited peaks for monitoring via NMR titrations.
However, we discovered that the length of the carbon chain did matter significantly. The 6 carbon cationic guest did not show any qualitative results (see supplemental information), and was determined to be too small for both β-CD and γ-CD
[2]pseudorotaxane formation. The 8, 10, and 12 carbon cationic guests all showed
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well-defined chemical shifting, with the 12 carbon being the most significant (represented in Figure 16) – including shifting of the aliphatic region that did not demonstrate any shifting with previous guests of this subgroup, meaning it must be the
strongest of the series to bind into CD, shown qualitatively in Figure 17. Ultimately,
making it the best candidate for ternary complex formation, which is why we decided
to pursue that model for ternary complex observations. The changes in chemical shift
for all guests is summarized in Table 1.

Figure 16. 12C guest, 8, bound in the cavity of CD. Best suited [2]pseudorotaxane for ternary complexation.
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Figure 17. Zoomed in spectra of the 12 carbon alkyl-based cationic guest in CD.
Note: all trends are seen in β-CD and γ-CD.
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Alkyl
imidazolium
threads

Chain
length of
thread

∆δ imidazolium(1H)
(ppm)

∆δ imidazolium(2H)

∆δ methylene (2H)

(ppm)

(ppm)

(# carbons)

5

6

negligible

negligible

negligible

6

8

-0.0371

-0.2271

-0.0212

7

10

-0.0884

-0.0662

-0.0523

8

12

-0.0643

-0.0578

-0.0472

Table 1. Chemical shift trends for the alkyl imidazolium threads in D2O.
We considered the 5 to be negligible, as no change in chemical shift was observed, therefore showing no binding. The corresponding association constants for
complexes with guests 6-8 are summarized in Table 2. An interesting trend can be
seen, that alkyl chain length does play a role in binding. Guest 6 was most significant
qualitatively, however when calculating associations for the guests, 5-8, higher binding was achieved quantitatively with the longer chain, 8. It is possible that there are
two guests in CD when the guest is 7, which is consistent with it’s qualitative analysis,
as an curious trend is observed at the 1:1 host:guest ratio, shown qualitatively in Figure 18.
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Figure 18. Zoomed in spectra of the 10 carbon alkyl-based cationic guest in CD,
in which an interesting trend is seen at 1:1 host:guest complexation.
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Alkyl imidazolium threads

Chain length
of thread

Association constant

(# of carbons)

(KA)

Assumptions

5

6

negligible

negligible

6

8

55.2 +/- 4.4 M-1

1:1

7

10

1.9e2 +/- 20 M-1

1:1

8

12

6.1e3 +/- 31 M-1

1:1

Table 2. Calculated association constants for the alkyl imidazolium guests.
It is important to note that all calculations obtained from supramolecular.org were
assuming a 1:1 complexation was occurring. It is probable that 1:2 host:guest binding
was occurring in γ-CD specifically, as it’s internal cavity size is so large, however we
were unable to determine a reliable method of calculating such a system, therefore do
not have reliable quantitative associations assuming any 1:2 complexation. All data
summarized in Tables 1 and 2 are specific to β-CD, however, similar qualitative trends
are observed with γ-CD.
Content with these results, we felt that we found our ideal guest, 8, to form a ternary complex with. As previously discussed, we decided to do our preliminary studies
using dodecylphosphocholine to simulate that of an APL-based drug.
We postulated that the aliphatic chain would predominate in binding in CD, however, CD seems to prefer the cationic regions in comparison to the entirely hydrophobic region. This is a confirmed trend our group has seen numerous times. When introducing the dodecylphosphocholine into the [2]pseudrotaxane, the same trend occurred,

79

in which the zwitterionic region of the drug-mimic showed the most promising qualitative results (see Supplemental Info). It is possible that the charged regions are interacting with the periphery hydroxyl groups on CD, but it is also possible that there are
some other non-covalent forces driving this phenomenon. In terms of the 10 carbon
guest, 7, we postulate that there may be cation-π interactions occurring between imidazolium groups on the guest, allowing the aliphatic chain to bend inside the
cavity of CD.
The data was not conclusive upon conducting numerous 2D NMR experiments,
which are planned to be optimized. Additional experimentation, including molecular
simulations, are needed to further confirm exact binding profiles of the ternary complex. From what we have previously observed in addition to what is seen qualitatively
on NMR, we feel confident saying that majority of binding is occurring at the zwitterionic region of the drug moiety, predominately the ammonium group, which showed a
large change in terms of change in chemical shift when conducting 1H NMR titration
experiments. The proposed binding arrangement is demonstrated in Figure 19.
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Figure 19. Proposed spatial arrangement of ternary complex.
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3. CONCLUSION
We have successfully synthesized a broad library of CD-based [2]pseudorotaxanes
with various types of guests, including both neutral and cationic species containing aliphatic internal chains and PEG-based internal chains. As previously mentioned, more
experimentation on the ternary complex formation needs to be investigated.
Due to the large gaps in literature regarding these types of ternary complexes, it is
quite difficult to determine exact spatial arrangements with the hetero[3]pseudorotaxane systems. Despite this, we have discovered some fundamental findings regarding
the binding patterns of CDs.
Charged moieties, particularly cationic species, preferentially bind into CDs. Even
more so than their hydrophobic partners. It is possible that some form of cation-π interaction is occurring, which is a fundamental area of research that needs further exploration.
Additionally, we hope to perfect this system and be able to use it for drug delivery.
This type of model could also be used for other purposes, such as biosensing and environmental remediation.
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SUPPLEMENTAL INFORMATION
CHAPTER TWO:
CYCLODEXTRIN-BASED PSEUDOROTAXANES: SUPRAMOLECULAR
SCAFFOLDS FOR DRUG BINDING AND DRUG DELIVERY

General Considerations:
A. Reagents
All chemicals were purchased from Sigma-Aldrich, Fisher Scientific, and TCI
chemicals, and used as received unless stated otherwise. Deuterated solvents using for
NMR analysis were purchased from Cambridge Isotope Laboratories and stored
appropriately. All reagents were stored under an inert atmosphere before use. Unless
otherwise noted, all reactions were performed under N2.
B. Instrumentation
NMR spectra were obtained using a Bruker Advance 300 MHz and 400 MHz
spectrometers. Low resolution mass spectrometry was performed using a Shimadzu
LRMS-2020. High resolution mass spectrometry was performed using a Thermo
Scientific LTQ Orbitrap XL™ mass spectrometer.
C. Determination of association constants for host cyclodextrins and guests
The NMR titration experiments were conducted per the following procedures. A
series of NMR samples were prepared in 5mm NMR tubes. 20mM stock solutions of
β-CD, γ-CD, and guests were prepared using DMSO-d6 as the solvent. Using the
above stock solutions, 0.25 mL of the host and 0.25 mL of the guest were mixed inside
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a GC vial. The threading of the guest into the host was achieved by heating the solution inside the vial to 60 oC for 5 min. This solution was then cooled to room temperature and transferred to an NMR tube. Physical observation of inclusion complex was
seen by the turbidity of the cooled solution. 1H NMR spectra were then acquired at
298 K. 1H NMR was performed to see the movement of the protons in the guest, the
movement of the guests after the inclusion complexes were formed, and to monitor the
ternary complex once the interlocked kinetically stable rotaxane was formed. The data
was evaluated using supramolecular.org website, previously cited in Chapter 1.
In order to achieve ternary complexation, a 1:1 host:guest 20mM stock solution was created and sonicated for 15 minutes until the turbidity of the solution was
observed, indicating pseudorotaxane formation. Various concentrations of the dodecylphosphocholine was then titrated into 5mm NMR tubes in various stoichiometric
conecentrations. 1H NMR spectra were then acquired at 298 K. The movement of the
zwitterionic peaks were monitored to observe the protons in the new guest, or drug
mimic.
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D. Syntheses and characterization
N
N

N

N

Supporting Figure S. 45. Representative syntheses for guests (1-4).
Representative syntheses for guests (1-4). Imidazole (5 mmol), 1,8-dibromodecane (1
mmol), and potassium hydroxide (6 mmol) were dissolved in isopropanol (15 mL) and
stirred at 70 ºC for 12 hours. Once complete, the solvent was evaporated under reduced pressure and redissolved in 40 mL of deionized water. The resulting mixture
was extracted with dichloromethane (3 x 25 mL), and the combined organic layers
were washed with water and brine. The organic layers were dried under reduced pressure and concentrated in vacuo overnight. (89% yield). Spectral data matched the literature reported values. Note: the same procedure was repeated by substituting the
length of the dibrominated aliphatic chain.

87

Supporting Figure S. 46. Proton spectrum of guest 1.

Supporting Figure S. 47. Proton spectrum of guest 2.
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Supporting Figure S. 48. Proton spectrum of guest 3.

Supporting Figure S. 49. Proton spectrum of guest 4.
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Br
N
N

N

N
Br

Supporting Figure S. 50. Representative syntheses for guests (5-8).
Representative syntheses for guests (5-8). 1-methylimidazole (3 mmol) and 1,8-dibromodecane (1 mmol) were dissolved in toluene (5 mL) and refluxed for 12 hours. Once
complete, the toluene was decanted, and the crude product was triturated with diethyl
ether several times. The ether was filtered off, and the resulting product was then dried
under vacuum until a solid product formed (82% yield). Spectral data matched the literature reported values. Note: the same procedure was repeated by substituting the
length of the dibrominated aliphatic chain.
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Supporting Figure S. 51. Proton spectrum of guest 5.
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Supporting Figure S. 52. Proton spectrum of guest 6.
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Supporting Figure S. 53. Proton spectrum of guest 7.
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Supporting Figure S. 54. Proton spectrum of guest 8.
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N
N

O

O

N

N

Supporting Figure S. 55. Representative syntheses for guests (9-11).
Representative syntheses for guests (9-11). Imidazole (5mmol), triethylene glycol
(1mmol), and potassium hydroxide (6mmol) were dissolved in isopropanol (15 mL)
and stirred at 70 C for 12 hours. and stirred at 70 C for 12 hours. Once complete, the
solvent was evaporated under reduced pressure and redissolved in 40 mL of deionized
water. The resulting mixture was extracted with dichloromethane (3 x 25 mL), and the
combined organic layers were washed with water and brine. The organic layers were
dried under reduced pressure and concentrated in vacuo overnight. (85% yield). Spectral data matched the literature reported values. Note: the same procedure was repeated
by substituting the length of the PEG chain between tri-, tetra-, and penta-ethylene
glycol.
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Supporting Figure S. 56. Proton spectrum for guest 9.

96

Supporting Figure S. 57. Proton spectrum for guest 10.
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Supporting Figure S. 58. Proton spectrum for guest 11.
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Supporting Figure S. 59. Representative syntheses for guests (12-14).
Representative syntheses for guests (12-14). 1-methylimidazole (3 mmol), di-tosylated triethylene glycol (1 mmol) were dissolved in toluene (5 mL) and refluxed for 12
hours. Once complete, the toluene was decanted, and the crude product was triturated
with diethyl ether several times. The resulting product was then dried under vacuum
until a solid product formed (89% yield). Spectral data matched the literature reported
values. Note: the same procedure was repeated by substituting the length of the PEG
chain, between tri-, tetra-, and penta-ethylene glycol.
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Supporting Figure S. 60. Proton spectrum for guest 12.
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Supporting Figure S. 61. Proton spectrum for guest 13 in D2O.
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Supporting Figure S. 62. Proton spectrum for guest 14.
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13C

NMR spectra for guests (1-14)

Supporting Figure S. 63. 13C NMR spectrum for guest 1.
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Supporting Figure S. 64. 13C NMR spectrum for guest 2.
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Supporting Figure S. 65. 13C NMR spectrum for guest 3.
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Supporting Figure S. 66. 13C NMR spectrum for guest 4.
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Supporting Figure S. 67. 13C NMR spectrum for guest 5.
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Supporting Figure S. 68. 13C NMR spectrum for guest 6.

108

Supporting Figure S. 69. 13C NMR spectrum for guest 7.

109

Supporting Figure S. 70. 13C NMR spectrum for guest 8.
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Supporting Figure S. 71. 13C NMR spectrum for guest 9.
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Supporting Figure S. 72. 13C NMR spectrum for guest 10.
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Supporting Figure S. 73. 13C NMR spectrum for guest 11.
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Supporting Figure S. 74. 13C NMR spectrum for guest 12.
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Supporting Figure S. 75. 13C NMR spectrum for guest 13.
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Supporting Figure S. 76. 13C NMR spectrum for guest 14.
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E. 1H NMR titrations for [2]pseudorotaxanes with β-CD in DMSO-d6 representative titrations for each subgroup of guest in D2O.
Note: for all titrations shown, the guest reference is on the bottom, the titrations are shown in order of increasing ratios, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, and 4:1, of
guest to monitor the changes in chemical shift of the guest peaks. Most titration
spectra will be zoomed in at the cationic regions for the imidazolium guests.

Supporting Figure S. 77. 1H NMR titration of guest 1. No shifting observed.
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Supporting Figure S. 78. 1H NMR titration of guest 2.
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Supporting Figure S. 79. 1H NMR titration of guest 3.
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Supporting Figure S. 80. 1H NMR titration of guest 4.
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Supporting Figure S. 81. 1H NMR titration with guest 3 in D2O.
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Supporting Figure S. 82. Zoomed 1H NMR titration of guest 5 in D2O.
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Supporting Figure S. 83. Zoomed 1H NMR titration of guest 6 in D2O.

123

Supporting Figure S. 84. Zoomed 1H NMR titration of guest 7 in D2O.
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Supporting Figure S. 85. Zoomed 1H NMR titration of guest 8 in D2O.
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Supporting Figure S. 86. 1H NMR titration of guest 9.
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Supporting Figure S. 87.Zoomed 1H NMR titration of guest 10.
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Supporting Figure S. 88. 1H NMR titration of guest 11.
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Supporting Figure S. 89. Zoomed 1H NMR titration of guest 11.
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Supporting Figure S. 90. 1H NMR titration with guest 10 in D2O.
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Supporting Figure S. 91. Zoomed in 1H NMR spectra of guest 10. No shifting observed in D2O.
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Supporting Figure S. 92. 1H NMR titration of guest 12.
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Supporting Figure S. 93. 1H NMR titration of guest 13 in D2O. No shifting observed.
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Supporting Figure S. 94. 1H NMR titration of guest 14 in D2O. No shifting observed.
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E. 1H NMR titrations of ternary complexation with β-CD in D2O.

Complex Ref.

Drug Ref.

Supporting Figure S. 95. 1H NMR titration with [2]pseudorotaxane complex with
guest 8, and the drug-mimic, dodecylphosphocholine. Titration shown in increasing
concentrations of drug to complex. In order from bottom to top: drug reference, 1:4,
1:3, 1:2, 1:1, 2:1, 3:1, 4:1, and complex reference.
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Supporting Figure S. 96. 1H NMR titration with [2]pseudorotaxane complex with
guest 8 and dodecylphosphocholine, zoomed in at the zwitterionic region of the drug.
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Supporting Figure S. 97. 1H NMR titration with [2]pseudorotaxane with guest 8
and dodecylphosphocholine, zoomed in at the ammonium peak of the drug.
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CB6-BASED CLEAVABLE ROTAXANES: BIOSENSORS FOR THE EARLY DETECTION OF LUNG CANCER USING HYPERCEST 129XE MRI

Lauren E. Seveney, Carson Hasselbrink, Brenton DeBoef*

Department of Chemistry, Univeristy of Rhode Island, 140 Flagg Rd, Kingston,
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138

ABSTRACT
Interlocked molecules, like rotaxanes, are typically synthesized by threading a
linear axle-like molecule through a macrocyclic host. The thread is then held in place
by large, bulky molecular end caps that are coupled to the ends of the threads synthetically. This is a viable synthetic method, known as capping or locking, that we have
previously employed using various macrocyclic hosts and linear guests. This work focuses on the design and syntheses of a cucurbit[6]uril (CB6)-based rotaxane containing pH-sensitive cleavable axle. The synthetic design of the cleavable link will be discussed herein along with a simplistic [3+2} cycloaddition in which CB6 is known to
catalyze. The overall objective is to use these cleavable rotaxanes as novel biosensors
for the early detection of lung cancer by applying and producing a HyperCEST signal
capable of being monitored via 129Xe MRI.
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1. INTRODUCTION
In 2020, cancer took nearly 10 million lives and continues to be one of the
leading causes of death worldwide, with lung cancer consistently advancing, in terms
of newly diagnosed cases per year.1 Lung cancer mortality rates are extremely high,
approximately twice as high in comparison to other common types of cancer.2 Lung
cancer is largely diagnosed at stage IV, in which cancer has extensively metastasized
and is, in many cases, terminal to the patient.3 An overview of the stages of lung cancer is shown in Figure 18. One main consequence of these statistics is that there is an

Figure 20. Summary of the stages of lung cancer. Figure adapted from
www.saintjohnscancer.org
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absence of early diagnostic tools that are accurate and sensitive enough to diagnose
lung cancer in its early stages.
A few reasons are attributed to the lack of cutting edge research in this field –
there is an inherent stigma attached to lung cancer, that it is exclusively linked to
smoking addition and thus often times ignored in comparison to other types of cancer.
Additionally, it is also difficult in terms of symptomatic profiling, often leading to
misdiagnoses for other pulmonary infections. Diagnostic testing is readily available,
however, is generally prescribed too late and is not very reliable in most cases. Current
common diagnostic tests include: chest radiography4, low dose computed tomography
(LDCT)5, positron emission tomography (PET)6, magnetic resonance imaging (MRI)7,
and sputum cytology8,
However, the majority of these techniques rely on ionizing radiation, which
can be particularly harmful, especially in high dose or extenuating circumstances. Additionally, X-ray, MRI, and LDCT techniques do not have the ability to distinguish
whether a tumor is benign or malignant. The aforementioned methods are also not particularly accurate, with there being a high possibility of producing a false-positive
and/or false-negative result at the early stages of detection.4,9 Commonly used PET
imaging requires the patient to be injected with a radionuclide, Fluorodeoxyglucose18

F (FDG), which is time-sensitive and often results in poor spatial resolution.10 Addi-

tionally, it does not provide adequate anatomical information and is often combined
with CT. False-positive results can also happen due to the normal physiologic uptake
of FDG in mediastinum, which may result in an increased morbidity from unnecessary
surgical treatment, in conjunction with serious psychological burdens to the patients
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and their families.9,11 As a result, these current available techniques do not meet the requirements for reliable diagnostics at the early-stage of lung cancer.
CB6 is a desirable macrocycle for this work due to its capability to bind xenon
tightly, as well as, produce a HyperCEST signal. CBs are composed of glycouril subunits, or monomers, and can be easily synthesized by reacting glycouril with formaldehyde and sulfuric acid. The sizes of CBs are tunable, just like with other mentioned
macrocycles, CB6 simply has six repeating glycouril units linked by methylene
bridges, shown in Figure 19.

Figure 21. Representation of CB6.
Herein, we investigate a solution to this pressing problem: to provide an early
detection method of lung cancer using molecular imaging (MI) combined with a sufficient MI biosensor. MI is a non-invasive imaging approach, which solely requires injection of the MI biosensor. This biosensor should either have a high affinity in biologically recognizing cancerous cells or, to become “active” once it reaches the cancerous environment. The most common method of molecular imaging involves PET.
However, the previously listed challenges associated with use of PET for lung cancer
detection make it less desirable. These include: low spatial resolution, associated false142

positive and false-negative results, ionizing radiation, and half-life time of the PET
traces (commonly ~ 2 hours).
The use of hyperpolarized (HP) xenon-129 (129Xe) MRI may provide a way to
overcome the current challenges with early-stage lung cancer detection. HP 129Xe MI
has the potential to provide safer, more accurate imaging, using existing hospital imaging infrastructure and maintaining the sensitivity of PET.12 HP 129Xe MI relies on
observation of HP Chemical Exchange Saturation Transfer (HyperCEST) effect. HP
129

Xe MI is used in conjunction with supramolecular molecules, or a molecular

“cage”, that can effectively encapsulate HP 129Xe to produce a specific signal, shown
in Figure 20.
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Figure 22. Comparison of regular CB6 129-Xe exchange (control), with that of the HyperCEST effect when coupled with an MI biosensor. Figure from citation 24.

Once the HP supramolecular cage is injected in the body, HP 129Xe is dissolved in the blood and is continuously diffusing in and out of the molecular cage. By
applying a depolarizing saturation pulse at the chemical shift offset of the 129Xe in the
cage, the pool of HP 129Xe in the dissolved pool is decreased after depolarized 129Xe
leaves the cage. Digital subtraction of the saturated image from the non-saturated image results in a signal enhancement, shown in Figure 21, of up to a billion times above
thermal equilibrium, which can be seen in Fig. 20.
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Figure 23. Comparison of signal enhancement between regular
proton MRI, and HyperCEST 129-Xe MI. Figure adapted from:
erj.ersjournals.com/content/55/2/1901987#sec-2
Despite numerous studies of HP 129Xe MI agents15–18, almost all of them were
conducted in vitro in different chemical solutions. Recently, we have demonstrated,
for the first time, the HyperCEST effect of the CB6 supramolecular cage in whole
blood samples.23 The minimum detectable concentration of CB6 in blood is roughly
10uM and the highest HyperCEST depletion observed was equal to 80%. Following
these formative results, we were able to demonstrate, for the first time, HP 129Xe MI in
a living rat.24 We produced images of the heart, lungs, kidneys, aorta, and the brain using CB6 as HP 129Xe HyperCEST MI agent. As shown in Figure 22, we demonstrated
the observed biodistribution of CB6 in the living animal detected in our clinical MRI
scanner. With our expertise in imaging CB6 biosensors in vivo, we feel confident that
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Figure 24. HyperCEST saturation map of rat model. Accumulation is noted in the heart (top of image), lungs, liver, aorta
(midline), and the kidneys (lateral to aorta, upper abdominal quadrants). B) Zoomed image of the rat brain.24
we will be able to extend this work and subsequently image the presence of lung cancer using our synthesized CB6-based rotaxane biosensors.
Our hypothesis is that early-stage lung cancer detection with sensitivity of PET
and with superior spatial resolution of MRI is possible by utilizing HP 129Xe HyperCEST MI. In order to demonstrate this, we are planning to synthetize a family of cucurbit[6]uril (CB6)-based MRI biosensors suitable for the early detection of lung cancer. CB6 is well-know supramolecular cage for HyperCEST molecular imaging.13–20
To render it for early cancer detection, we propose a CB6-based cleavable rotaxane
that is sensitive to cancerous biological environment and thus becomes active only
near the cancerous cells. The major property of cancer tumors is altered nutritional and
metabolic environment. The functional vasculature of tumors is always insufficient for
tumor needs, which leads to nutrients deficiency and to decreased transport of tumor’s
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metabolic products.21 The increased metabolic consumption of glucose during fermentative glycolysis creates excessive amount of lactic acid and other compounds
which make a biggest contribution into extracellular acidosis in solid tumors with extracellular pH values as low as 6.5.22 Therefore, our goal is to develop a CB6-based
rotaxane that can cleave, or become “active”, under acidic conditions, making it an active HP 129Xe MI agent specific to the cancerous site.
Interlocked molecules, like rotaxanes are typically synthesized by threading
the linear axle-like molecule through a macrocyclic host. The thread is then held in
place by large molecular caps that are coupled to the ends of the threads. This is a viable synthetic method that we have used to synthesize [2]- and [3]-rotaxanes with various macrocyclic hosts. However, for the work herein, we will introduce the synthesis
of CB6-based rotaxanes with cleavable axles using a robust and high-yielding reaction
that is perfectly suited for this application: the CB6-catalyzed [3+2] cycloaddition.
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2. RESULTS
We began the synthesis of the two “halves” of the molecular axle. We hypothesize that the presence of imidazole on both “halves” will circumvent any water solubility issues. We have previously found that imidazole groups are excellent for this
purpose, and easily adjusted synthetically to become functionalized and therefore cationic – which would ultimately enhance water-solubility even more. We have designed
a convergent synthetic approach, shown in Figure 23, in order to minimize complexity, potential challenges, and number of steps. Most simplistically, we based our design, described herein, with one of the “halves” of the molecular axle containing an alkyne with a disulfide, and the other containing an azide in preparation for the [3+2]
CB6-catalyzed cycloaddition. The most crucial step for this synthesis was 4, as it was
needed for both azide and alkyne sides of the molecules.
As described in Fig. 23, we embarked on the synthesis by reacting benzylimidazole, 1, with ethylene carbonate, 2, and refluxed in toluene as the desired solvent according to literature procedure for 5 hours with a high yield, to generate 3. Next, we
did a routine SN2 using thionyl chloride in dichloromethane as the solvent for two
hours, which gives quantitative yields, to generate 4, the key intermediate, to swap out
the chlorine leaving group for our desired azide moiety, 5, using common conditions.
Next, we initiated the synthesis of 6 by using commercially available propargyl
bromide, 5, and reacting it with thioacetic acid and potassium carbonate as the desired
base for 12 hours, achieving a 68% yield.
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Lastly, we took molecules 4 and 6 and conducted an asymmetrical disulfide
synthesis, a more unknown reaction but present in literature, using catalytic amounts
of cesium carbonate, thiosulfate as the new sulfur source, water as the solvent, and reacted that for 24 hours at 70°C with sufficient yields to generate the other half of our
rotaxane, 7.
Key intermediate step

O

N
N
H
1

O

O

N

Toluene
Reflux
5h
88%

N

3

2

SOCl2
DCM
2h
Quant.
4

OH

N

NaN3

N

N

DMF, 60ºC
5h
Quant.

N

Cl

N3
5

Cs2CO3 (15 mol%)
N

Na2S2O3
H2O
70 ºC, 24 h
65% (crude)

N

S
O

S
O

SH

Br
5

S

K2CO3
12 h
68%

6

7

Figure 25. Complete synthetic route for the two "halves" of the guests in preparation for the CB6 catalyzed [3+2] cycloaddition.
We have designed this synthesis to be easily modifiable at several points, with
the purpose of being able to accommodate any unforeseen experimental challenges.
We chose a disulfide moiety as our pH-sensitive cleavable moiety, as they prove to be
easily reduced in acidic environments. As well as using benzylimidazole derived end
caps, which are large enough to interlock the rotaxane in place, based off molecular
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modeling simulations conducted. See the supplemental information for all experimental details and characterization.
However, both aspects of this design—cleavable group and end cap, can be replaced by introducing alternative moieties to provide several alternate syntheses to
generate a scope of various CB6-cleavable rotaxanes to make them more chemically
robust. The end key step is the [3+2] cycloaddition, demonstrated in Figure 26, which
has been reported to take place on immensely short timescales once introducing CB6
to the reactants, which is heavily reported to successfully catalyze the cycloaddition to
yield the triazole moiety.

Figure 26. Key end step involving the CB6 catalyzed [3+2] cycloaddition to yield
the kinetically stable rotaxane.
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3. CONCLUSION
We have discovered a new synthetic design and approach to generate a cleavable rotaxane when introduced to a reducing environment, such as a lung cancer microenvironment. Coupled with 129Xe gas in the interior cavity of the CB6-based rotaxane,
this provides the field with an innovative and much needed way to diagnose lung cancer in its early stages, which is a significant problem in the medical community, and
most importantly, to those suffering with the disease.
The essential next task was to generate a experimental reducing environment to
mimic a lung cancerous microenvironment. This will be done by introducing a mild
reducing agent, such as sodium borohydride, to see if the disulfide bond cleaves when
introduced to the simulated reducing environment. When successful, our fellow colleagues in Thunder Bay, Ontario, Canada will test its viability to produce a HyperCEST signal and thus monitor by 129Xe MRI.
The synthesis can easily be revised if needed, however, we believe we came up
with a relatively simple convergent approach. The concluding tests will involve in
vitro studies, similar to the aforementioned work involving the CD-based pseudorotaxanes for this application. We hope that this dual biosensing and advantageous MI system works for future purposes and applications as well, potentially even neurodegenerative disorders, which are also diagnosed in their late, nearly terminal, stages.
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SUPPLEMENTAL INFORMATION
CHAPTER THREE:
CB6-BASED CLEAVABLE ROTAXANES: BIOSENSORS FOR THE EARLY DETECTION OF LUNG CANCER USING HYPERCEST 129Xe MRI

General Considerations:
A. Reagents
All chemicals were purchased from Sigma-Aldrich, Fisher Scientific, and TCI
chemicals, and used as received unless stated otherwise. Deuterated solvents using for
NMR analysis were purchased from Cambridge Isotope Laboratories and stored appropriately. All reagents were stored under an inert atmosphere before use. Unless otherwise noted, all reactions were performed under N2.
B. Instrumentation
NMR spectra were obtained using a Bruker Advance 300 MHz and 400 MHz
spectrometers. Low resolution mass spectrometry was performed using a Shimadzu
LRMS-2020. High resolution mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™ mass spectrometer.
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C. Syntheses and characterization

Supporting Figure S. 98. Synthesis of 3.
Synthesis of 2-(1H-Benzimidazol-1-yl)ethanol (3). A mixture of benzimidazole (4.4g,
37.5mmol) and ethylene carbonate (3.3g, 37.5mmol) were dissolved in 6mL of toluene
and refluxed for 5 hours. After cooling, the bottom layer was excessively washed with
diethyl ether to yield a thick white solid. The diethyl ether was decanted, and the resulting solid was left on vacuum at 85 °C overnight. The resulting solid was then triturated with diethyl ether and vigorously stirred overnight to yield a fine white powder.
No further purification was needed. Yield: 3.7g, 60%. LCMS ESI (m/z): [M+H] calculated for C9H10N2O 162.08, observed 207 (K+ adduct). 1H NMR (400 MHz, DMSOd6.; δ: 1H NMR (400 MHz, DMSO-d6) δ 8.16 (s, 1H), 7.67 – 7.58 (m, 2H), 7.26 – 7.15
(m, 2H), 4.28 (t, J = 5.4 Hz, 2H), 3.73 (t, J = 5.4 Hz, 2H). 13C NMR (101 MHz,
DMSO-d6) δ 144.94, 143.87, 143.21, 134.53, 122.56, 121.84, 121.78, 119.75, 115.87,
111.03, 60.11, 47.43.
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Supporting Figure S. 99. Proton spectrum of 3.
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Supporting Figure S. 100. 13C spectrum of 3.

Supporting Figure S. 101. Mass spectrum of 3.
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Supporting Figure S. 102. Synthesis of 5.
Synthesis of azide (5). The crude chloride precursor, 4, was dissolved in 10mL of
DMF, with NaN3 (2 equiv., 800mg). The resulting mixture was heated to 60ºC for 5
hours. The reaction mixture was then poured into 50mL of water, and extracted with
ethyl acetate (2x50mL). The combined organic layers were then washed with brine
(2x50mL) and dried over Na2SO4. The reaction mixture was then concentrated in
vacuo and dried overnight to yield pure product. Yield: Quantitative. 1H NMR
(400 MHz, DMSO-d6.; δ: 1H NMR (400 MHz, DMSO-d6) δ 8.16 (s, 1H), 7.67 – 7.58
(m, 2H), 7.26 – 7.15 (m, 2H), 4.28 (t, J = 5.4 Hz, 2H), 3.73 (t, J = 5.4 Hz, 2H). 13C
NMR (101 MHz, DMSO-d6) δ 144.95, 144.68, 143.84, 134.20, 122.94, 122.92,
122.39, 122.16, 119.94, 115.78, 110.98, 110.91, 50.62, 46.27, 44.06, 44.01.
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Supporting Figure S. 103. Proton spectrum of 5.
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Supporting Figure S. 104. 13C spectrum of 5.
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Supporting Figure S. 105. Synthesis of 6.
Synthesis of thioacetate (6). Propargyl bromide, (1 equiv.), was mixed with thioacetic
acid, (2 equiv.), and potassium carbonate (2.5 equiv) neat for 12 h. Yield: 68%. 1H
NMR (400 MHz, DMSO-d6) δ 3.68 (d, J = 2.7 Hz, 4H), 3.14 (td, J = 2.6, 0.7 Hz, 2H),
2.37 (s, 6H), 1.91 (s, 1H). 13C NMR (101 MHz, DMSO-d6) δ 194.32, 172.82, 80.11,
73.67, 30.55, 21.86, 17.30.
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Supporting Figure S. 106. Proton spectrum of 6.
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Supporting Figure S. 107. 13C spectrum of 6.
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Supporting Figure S. 108. Synthesis of 7.

Synthesis of disulfide-containing terminal alkyne (7). A mixture of the generated thiosulfate, 6, (0.5 mmol), sodium thiosulfate (1.5 mmol), benzimidazole-ethyl-chloride
(0.75 mmol), cesium carbonate (15 mol%), and water (5 mL) was stirred in an open
round bottom flask. The resulting mixture was stirred at 70°C in the air for 24 h. Once
completed, the reaction mixture was extract with ethyl acetate (3 x 5mL), organic solvent was removed, and the residue was separated by column chromatography by using
mixed hexanes:ethyl acetate 50:1 (v/v) as an eluent to afford the desired product.
Crude yield: 65%. LCMS ESI (m/z): [M+H] calculated for C12H12N2S2 248.04, observed 257 (MeOH adduct).
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Supporting Figure S. 109. Proton spectrum of 6 (crude).

Supporting Figure S. 110. Mass spectrum of 6 (crude).

167

